Repligen Appoints Jacob Johnson As Vice President Investor Relations

Group 1 - Repligen Corporation appointed Jacob Johnson as Vice President of Investor Relations, who will lead the investor relations team and report to CFO Jason K. Garland [1][2] - Jacob Johnson has a strong background in the life sciences tools and pharma services sector, having covered Repligen as a research analyst since 2019, which will facilitate his engagement with investors [2] - The outgoing Vice President of Investor Relations, Sondra Newman, is retiring after a successful tenure since 2012, during which she led global investor relations and corporate communications [2] Group 2 - Repligen Corporation is a global life sciences company focused on developing innovative bioprocessing technologies for the manufacturing of biological drugs [3] - The company serves biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide, with a focus on areas such as Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [3] - Repligen's headquarters are located in Waltham, Massachusetts, with manufacturing sites primarily in the U.S. and additional key locations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [3]